Related references
Note: Only part of the references are listed.Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial (vol 149, pg 521, 2008)
G. Simonneau et al.
ANNALS OF INTERNAL MEDICINE (2009)
Tadalafil Therapy for Pulmonary Arterial Hypertension
Nazzareno Galie et al.
CIRCULATION (2009)
A meta-analysis of randomized controlled trials in pulmonary arterial hypertension
Nazzareno Galie et al.
EUROPEAN HEART JOURNAL (2009)
Updated Evidence-Based Treatment Algorithm in Pulmonary Arterial Hypertension
Robyn J. Barst et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Cellular and Molecular Basis of Pulmonary Arterial Hypertension
Nicholas W. Morrell et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Diagnosis and Assessment of Pulmonary Arterial Hypertension
David B. Badesch et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Uncertainties in the diagnosis and treatment of pulmonary arterial hypertension
Hossein A. Ghofrani et al.
CIRCULATION (2008)
Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib
Elizabeth Day et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Addition of Sildenafil to Long-Term Intravenous Epoprostenol Therapy in Patients with Pulmonary Arterial Hypertension A Randomized Trial
Gerald Simonneau et al.
ANNALS OF INTERNAL MEDICINE (2008)
Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib
Tammy F. Chu et al.
LANCET (2007)
Flying under the radar:: the new wave of BCR-ABL inhibitors
Alfonso Quintas-Cardama et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
A meta-analysis of trials of pulmonary hypertension: A clinical condition looking for drugs and research methodology
Alejandro Macchia et al.
AMERICAN HEART JOURNAL (2007)
Clinical pharmacology: Concise drug reviews
Christine E. De Kogel et al.
ONCOLOGIST (2007)
Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia
Brian J. Druker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension
Vallerie V. McLaughlin et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Long term imatinib treatment in pulmonary arterial hypertension
R. Souza et al.
THORAX (2006)
Cardiotoxicity of the cancer therapeutic agent imatinib mesylate
Risto Kerkela et al.
NATURE MEDICINE (2006)
Imatinib mesylate in the treatment of refractory idiopathic pulmonary arterial hypertension
Karen C. Patterson et al.
ANNALS OF INTERNAL MEDICINE (2006)
Sildenafil citrate therapy for pulmonary arterial hypertension
N Galiè et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Reversal of experimental pulmonary hypertension by PDGF inhibition
RT Schermuly et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Imatinib for the treatment of pulmonary arterial hypertension
HA Ghofrani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Alterations in Ca2+ cycling by lysoplasmenylcholine in adult rabbit ventricular myocytes
SJ Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2003)
Bosentan therapy for pulmonary arterial hypertension
LJ Rubin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Share Paper
